Exact Sciences has announced the FDA approval of Cologuard, the first non-invasive DNA screening test for colorectal cancer.
Nonadherent MRI utilization is tied to a cascade of higher medical costs and potentially unnecessary and unhelpful medical services following the MRI.
For children with pelvic fractures or dislocations after blunt trauma, plain anteroposterior pelvic radiographs have limited sensitivity.
The FDA has issued a final guidance on the development, review, and approval or clearance of companion diagnostics.
Millions of American women have benefited from a breast and cervical cancer screening program offered by the CDC.
Measurement of the peripheral pulse (MPP) at the radial artery is feasible as a simple noninvasive screening tool for paroxysmal atrial fibrillation (pAF).
Among patients who have a prostate biopsy that is negative for cancer, an epigenetic assay may identify those who do not require repeat biopsy.
Review this chart for quick information when you need it.